Krystal Biotech
KRYS
KRYS
298 hedge funds and large institutions have $4.93B invested in Krystal Biotech in 2025 Q1 according to their latest regulatory filings, with 65 funds opening new positions, 87 increasing their positions, 112 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
298
Holders Change
+35
Holders Change %
+13.31%
% of All Funds
4.05%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.1%
New
65
Increased
87
Reduced
112
Closed
28
Calls
$54.2M
Puts
$17.6M
Net Calls
+$36.5M
Net Calls Change
+$10M
Top Buyers
1 |
UBS AM
Chicago,
Illinois
|
+$65.9M |
2 |
B
Braidwell
Stamford,
Connecticut
|
+$36.1M |
3 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$33.5M |
4 |
![]()
1832 Asset Management
Toronto,
Ontario, Canada
|
+$24.5M |
5 |
ACA
Avoro Capital Advisors
New York
|
+$18.4M |